Al Riyadh Daily Newspaper – May 2, 2025: Pharmaceutical Industry, Artificial Intelligence, Geopolitical Landscape

These excerpts from Al Riyadh newspaper discuss various aspects of Saudi Arabia’s advancements and initiatives, particularly under the umbrella of Vision 2030. Key areas covered include the rapid growth and localization of the pharmaceutical industry, highlighting government support, international partnerships, and the goal of achieving drug security and becoming a global hub. The sources also touch on the geopolitical landscape and the race for technological dominance, focusing on the competition in Artificial Intelligence between the US and China and the critical need for sustainable energy sources to power this progress. Furthermore, the text explores social and cultural shifts in the Kingdom, mentioning the increasing participation of women in various sectors, the development of the real estate market and its digital transformation, and artistic expressions rooted in Saudi heritage. Finally, the articles detail the Saudi Arabian football landscape, focusing on the AFC Champions League final and the historical significance of the Saudi Arabian Football Federation’s restructuring of domestic competitions.

Saudi Arabia’s Vision 2030: Progress and Challenges

Saudi Vision 2030 is presented in the sources as an ambitious strategic roadmap for the Kingdom of Saudi Arabia, approved by King Salman bin Abdulaziz on April 25, 2016 (Rajab 18, 1437H), based on a resolution issued by the Council of Economic Affairs and Development on April 19, 2016 (Rajab 12, 1437H). The Vision is built upon the Kingdom’s strengths, which are its strategic depth connecting three continents, its investment power, and its Islamic and Arabic standing. At its core, the Vision prioritizes empowering citizens and diversifying the economy.

The Vision aims to achieve unprecedented growth opportunities and economic prospects. It is being implemented through integrated national strategies, ambitious projects, and various programs to establish a lasting impact. Vision 2030 envisions a future where culture and innovation progress hand in hand, keeping pace with rapid global changes and benefiting citizens, residents, and visitors alike.

A key focus of Vision 2030 is economic diversification and reducing reliance on imports. This includes aiming for self-sufficiency in vital sectors such as the pharmaceutical industry, which is considered a fundamental pillar for strengthening health security and diversifying the economy. The Kingdom aims to raise the percentage of local drug manufacturing to 70%, significantly reduce dependence on imports, and increase the pharmaceutical sector’s contribution to the national GDP from less than 1% in 2020 to about 3-4% by 2030. Achieving self-sufficiency in the drug industry is seen not merely as an economic option but a strategic necessity for health and economic stability. The Vision seeks to transform the Kingdom into a leading global center in the pharmaceutical sector.

Vision 2030 also emphasizes empowering national competencies and developing human capital. Enabling women is a fundamental part of this strategic transformation. Saudi women have demonstrated high capabilities in various fields within the health sector, from research and development to manufacturing and management. There are significant opportunities for Saudi women to participate in advanced genetic research, drug development, and manufacturing techniques. The Vision aims to raise the rate of women’s participation in the labor market to 40% by 2030.

Driving innovation and technology adoption, including Artificial Intelligence (AI), is another core element. The Kingdom places great importance on integrating AI in the drug industry to accelerate innovation and improve production. Saudi universities play a pivotal role in enhancing the digital transformation of the national drug sector by developing research infrastructure and qualifying specialized national personnel.

To attract investment and stimulate the sector, Vision 2030 includes strategies to attract both national and foreign investments. This is supported by government backing, international partnerships, modern infrastructure, and financial and legislative incentives. Initiatives like “Made in Saudi Arabia” and programs for localizing the pharmaceutical industry are part of this effort. The Kingdom also encourages partnerships with global pharmaceutical companies to establish local factories or joint ventures, facilitating technology and knowledge transfer. Specialized industrial cities, such as Jubail and Yanbu, provide strong infrastructure for the drug industry and have attracted investments.

Beyond pharmaceuticals, Vision 2030 has driven transformations in other sectors:

• Real Estate: Decisions have been made to restructure the real estate market, aiming to lower prices, boost ownership, and ensure social justice, including freeing up large areas of land for development. There are plans to announce millions of real estate plots for registration and launch value-added services and a real estate registry platform.
• Energy/Petrochemicals: The Kingdom is the fourth largest global producer of petrochemicals and possesses the necessary components for further growth. Efforts focus on optimizing the use of hydrocarbons, finding innovative and sustainable applications for petrochemical materials, and increasing demand in the global market. There are plans to produce 3 million tons of clean hydrogen annually by 2030 in Jubail and Ras Al Khair. Jubail is also home to the largest integrated projects for refining and petrochemicals and the largest center for capturing, storing, and utilizing carbon dioxide in the Middle East.
• Quality of Life and Well-being: A vital community is one of the pillars of Vision 2030, aiming to provide prosperity and flourishing for citizens, enhance their pride in their history and identity, and offer a healthy and sustainable lifestyle with effective healthcare and social welfare systems. The annual report for the Vision for 2024 revealed significant progress in health and social welfare indicators, reflecting a qualitative transformation in the lives of Saudis. The average life expectancy reached 78.8 years in 2023, exceeding the target for 2025. The Kingdom ranked 11th among G20 countries in average life expectancy and saw a notable improvement in the quality of health services index in 2023. The rate of adults practicing physical activity for at least 150 minutes weekly reached 58.5%, an early achievement towards the 2030 target of 64%. The Kingdom ranked 32nd globally in the 2024 World Happiness Index.
• Work Environment: Vision 2030 is driving radical transformations in work environments to promote sustainable development and improve living standards. This includes enhancing labor legislation, providing supportive environments for women and youth, and encouraging companies to adopt best practices in occupational health and safety. These efforts have made work environments more diverse and inclusive, positively impacting employee satisfaction and productivity.
• Culture and Arts: The Vision fosters a future where culture and innovation are integrated. This includes promoting artistic and cultural production. Riyadh is set to launch the first edition of the “Downtown Design Riyadh” exhibition, a prominent platform in the contemporary design scene. Saudi participation has been noted in international art events like Art Dubai. New cultural institutions are being established, such as the first specialized college for arts at King Saud University.
• Sports: Vision 2030 supports the development of the sports sector, aiming to make Saudi clubs professional institutions with local, regional, and global impact. The Kingdom won the bid to host the 2034 FIFA World Cup and has created and hosted the first edition of the Esports World Cup. The Crown Prince plays a key role in the development of sports. Saudi clubs are participating in major Asian competitions, such as the AFC Champions League Elite.
• Tourism: The Kingdom has expanded electronic visit visas to 66 countries. Progress is being made on major tourism projects like Qiddiya. International tourist spending saw a significant increase compared to 2019. Al Madinah was listed among the top 100 tourist destinations globally for 2024, and AlUla was the first destination in the Middle East accredited by Destinations International.

Significant achievements highlighted in the sources include the completion of 85% of initiatives on the correct track, with 93% of Vision indicators meeting or exceeding their interim targets for 2024. The number of tourists exceeded 100 million visitors years ahead of schedule. The number of volunteers reached 1.2 million, surpassing the 2030 target. Women’s participation in the labor market reached 33.5%, exceeding the 2030 target of 30%. The unemployment rate saw a historic low. The Kingdom jumped 32 places in the e-participation index and 30 places in the UN e-government development index. The number of large companies exceeded the 2030 target. The number of pilgrims reached a historic high. Public investments tripled. The private sector’s contribution to GDP reached 47%, exceeding the 2024 target. Military industry localization exceeded its interim target. Four Saudi universities were ranked among the top 500 globally, with King Saud University entering the top 100. The Kingdom topped G20 countries in the IMD social responsibility index.

Despite the successes, the path towards achieving the Vision’s goals is not without challenges. These include the need for advanced manufacturing technologies for pharmaceutical localization, ensuring the supply of raw materials, the need to qualify more personnel in precise specializations like biological and experimental drug manufacturing, the high cost of operations compared to cheaper external markets, previous slowness in some regulatory procedures (though they have improved recently), limited local availability of raw materials leading to continued reliance on imports for some components, and competition with global companies on cost and quality.

Overall, Vision 2030 is presented as a comprehensive plan driving wide-ranging economic and social transformations, aiming for a prosperous economy, an ambitious nation, and a vital society, underpinned by a focus on efficiency, responsibility, transparency, and accountability in government operations. It represents a shift towards diversifying the economy and ensuring its sustainability.

Saudi Pharmaceutical Vision 2030 Transformation

Based on the sources and our conversation history, the pharmaceutical industry in Saudi Arabia is a critical focus area within the framework of Vision 2030, aiming for significant transformation and self-sufficiency.

Historically, before the 1970s, Saudi Arabia relied almost entirely on importing medicines from abroad, distributed by agents and trading companies, as there were no local factories. With the growth of the population and the development of health services during the era of King Faisal, the pressing need for localizing the drug industry emerged. The initial beginnings of pharmaceutical and medical production in the Kingdom were in 1975, though the first drug factory, Saudi Arabian Drug House Ltd., was established earlier in 1963.

Saudi Vision 2030 considers the pharmaceutical industry a fundamental pillar for strengthening health security and diversifying the economy [Conversation History]. The vision is linked to achieving a level of self-sufficiency in essential and antibiotic medicines. A core aim is to raise the percentage of local drug manufacturing to 70% by 2030 [Conversation History], significantly reducing dependence on imports [Conversation History]. The sector’s contribution to the national GDP is targeted to increase from less than 1% in 2020 to about 3-4% by 2030 [Conversation History]. Achieving self-sufficiency in this industry is viewed not just as an economic choice but a strategic necessity for health and economic stability [Conversation History]. The Kingdom aspires to become a leading global center in the pharmaceutical sector [Conversation History].

The sector has shown signs of global excellence. The Saudi pharmaceutical market is projected to reach 35 billion riyals (9.3 billion dollars) in 2024. It is considered the largest market in the Middle East and North Africa and a significant hub for global investments.

Key strategies driving the pharmaceutical industry under Vision 2030 include:

• Economic Diversification: The industry is central to diversifying the economy away from reliance on imports [Conversation History].
• Localization and Job Creation: Projects have contributed to “Saudization” by creating value-added jobs in areas such as R&D, quality engineering, manufacturing, and pharmaceutical operations management. The number of Saudis employed in the sector has increased by over 20% in the last three years. New jobs have been created not just in manufacturing but also in research and development (R&D), quality control, and pharmaceutical operations management.
• Innovation and Technology: There is an emphasis on adopting technology and innovation, including Artificial Intelligence (AI), to accelerate innovation and improve production [Conversation History, 4]. AI and automated control are being integrated into production lines. Saudi universities play a vital role by developing research infrastructure and qualifying specialized national personnel, contributing to the sector’s digital transformation [Conversation History, 7]. National clinical research programs have been launched in partnership with Saudi universities.
• Investment Attraction: Strategies aim to attract both national and foreign investments through government support, international partnerships, modern infrastructure, and financial and legislative incentives [Conversation History]. Initiatives like “Made in Saudi Arabia” and localization programs are part of this effort [Conversation History]. Partnerships with foreign companies are encouraged to establish local factories or joint ventures and facilitate technology and knowledge transfer [Conversation History, 3].
• Infrastructure Development: Specialized industrial cities like Jubail, Yanbu, Sudair, Jeddah, and Qassim offer robust infrastructure for the drug industry and have attracted investments [Conversation History, 8, 19].
• Regulatory Framework: The establishment of the Saudi Food and Drug Authority (SFDA) in 2003 has brought positive developments. SFDA has worked on a comprehensive regulatory system to ensure local products meet international standards. Procedures include adopting Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP), regular inspections of factories and warehouses, and facilitating product registration and licensing. SFDA’s membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and election to the ICH administrative committee reflect recognition of the efficiency of the Saudi regulatory system.
• Government Support: Local factories receive direct government support, including exemptions and incentives, which can allow for the pricing of medicines at supported rates or lower than imported equivalents.

Significant achievements noted include the successful localization of various technologies and specialized products for the first time. This includes the full manufacturing of a Biosimilar (Low molecular weight heparin/enoxaparin) and completing the first factory for high-tech dry powder inhalers (Dry Powder Inhalers and Metered Dose Inhalers) in the Gulf. The Kingdom has also announced capabilities for manufacturing sterile injectables and hosts the only factory in the Gulf for lyophilized products.

The Vision also emphasizes empowering national competencies, including enabling women [Conversation History]. The spread of pharmaceutical factories in industrial cities like Sudair, Jeddah, and Qassim has provided job opportunities for women in work environments that accommodate their privacy, leading to an increase in female employment in the sector. Saudi women are actively contributing to national drug security, enhancing local content in healthcare industries, and participating in developing innovative drug solutions, representing a significant transformation in the industry.

Despite progress, challenges in achieving the vision’s goals were mentioned in our conversation history. These include the need for advanced manufacturing technologies for localization, ensuring the supply of raw materials, the need for more personnel in specialized fields like biological and experimental drug manufacturing, the high cost of operations compared to cheaper external markets, previous regulatory procedural slowness (though noted to have improved recently), continued reliance on imports for some raw materials, and competition with global companies on cost and quality.

Saudi Real Estate Registration Reforms

Based on the provided sources, the real estate sector in Saudi Arabia has been undergoing significant reforms and qualitative developments in recent years in terms of regulations and legislation.

A prominent and fundamental development is the issuance of the In-rem Real Estate Registration system (نظام التسجيل العيني للعقار). By a decision from the Council of Ministers, the responsibility for In-rem Real Estate Registration was transferred from the Ministry of Justice to the General Real Estate Authority.

To handle and implement the In-rem Real Estate Registration work, a specialized company called the National Company for Real Estate Registration, also known as the “Real Estate Registry” (السجل العقاري), has been launched. This company operates according to international best practices and standards. The Real Estate Registry is notable for its accurate geographic maps.

Key outcomes of these developments mentioned in the sources include:

• New property title deeds are not subject to challenge.
• The Real Estate Registry eliminates duality.

Furthermore, the sources mention a Real Estate Developers Portal (بوابة المطورين العقاريين) which is expected to significantly change the dynamics of off-plan sales. The vision includes a digital identity for every property.

The President of the Real Estate Registry, Dr. Mohammed Al Sulaiman, was featured in a conversation with Al Riyadh newspaper regarding these matters.

The conversation history primarily focused on the pharmaceutical industry and does not contain information regarding the real estate sector.

Global AI Race: China vs. West

Based on the sources provided, the topic of AI competition is discussed, highlighting an accelerating race among major powers for technological dominance. This competition is primarily framed as being between Western companies and China.

Key points from the sources regarding this competition include:

• There has been remarkable progress achieved by the Chinese company “DeepSeek” in the field of AI.
• This progress has sparked “a wave of questions” in global technological and economic circles.
• The American company “OpenAI” has responded by announcing a “Deep Research” tool, which is seen as an attempt to maintain its leadership in the face of increasing Chinese competition. This announcement came shortly after DeepSeek’s progress became apparent.
• OpenAI’s move is described as a “direct response” to the emergence of advanced Chinese AI models, including “DeepSeek AI R1” (developed by DeepSeek), “Kimi Chat” (developed by Moonshot AI), and models produced by “Alibaba”.
• “Kimi Chat” has also shown “remarkable efficiency surpassing DeepSeek,” demonstrating a parallel capability in this competition.
• This technological development has raised questions about the “nature of strategies that Western companies will adopt” to face the “Chinese technological system” and the “extent of its impact on global technological competitiveness”.
• The competition involves major companies racing to develop more advanced AI models, while others focus on expanding the efficient use of these technologies, including considering costs.
• A fundamental question posed is whether the United States will be able to maintain its leadership or if China will reshape the rules of dominance.

While the sources discuss this global competition, they also mention Saudi Arabia’s engagement with AI. Artificial Intelligence and automated control are being integrated into production lines within Saudi Arabia, such as in the pharmaceutical industry. Saudi universities are playing a role in developing research infrastructure and qualifying national personnel for digital transformation in this sector. Additionally, a model called “Alam” has been included on the “Watsonx” platform. However, the sources do not connect Saudi Arabia’s AI activities directly to the global competition between Western companies and China discussed in source.

Our conversation history primarily focused on the pharmaceutical industry and real estate sectors and does not contain information related to AI competition.

Gaza Humanitarian Crisis and Aid Obstacles

Based on the provided sources, there is significant information regarding a crisis in Gaza, particularly focusing on the humanitarian situation and access to aid.

The sources indicate that Gaza is currently under a tight siege. Conditions there are described as being in their worst state since the war erupted in October 2023. The population faces widespread conditions for famine and disease.

A major aspect of the crisis is the difficulty of aid deliveries. Israel controls all crossings into the Gaza Strip, including international aid and necessary goods. According to one source, Israel has closed its doors to Gaza. Agencies from the United Nations and other international bodies state that there are insufficient aid supplies reaching the area and that the population is in danger.

Specific shortages are highlighted:

• Nine out of ten Palestinians in Gaza do not have access to safe drinking water.
• UN and other international agency storage and storage facilities are empty.
• All bakeries supported by a program (likely humanitarian aid) were closed as of March 31st due to the depletion of wheat flour and fuel.
• Food parcels designated for families have run out.

The situation is framed by some as a “starvation operation“. Humanitarian aid is reportedly being used as a weapon of war. The Israeli army, however, accuses the Hamas movement of exploiting aid, which Hamas denies. The Israeli army insists on the necessity of inspecting all incoming aid to prevent materials from reaching fighters, and aid deliveries have been stopped for this reason.

Regarding international intervention, the International Court of Justice (ICJ) has called on Israel to clarify what it is doing concerning the presence of United Nations and other international organizations. The ICJ ruling urges Israel to facilitate the delivery of urgent supplies that are essential for the survival of the civilian population, ensuring that no obstacles are placed. The source notes that the advisory opinions of the International Court of Justice are not legally binding. However, this specific advisory opinion is expected to increase diplomatic pressure on Israel.

There are 2.4 million Palestinians in the Gaza Strip who are in desperate need amidst this unprecedented humanitarian crisis.

Our conversation history primarily focused on the pharmaceutical industry, real estate, and AI competition and does not contain any information related to the Gaza crisis.

Saudi Pharmaceutical Industry Development and Security

Drug Industry Study Guide

I. The Saudi Drug Industry

• Vision 2030: The Saudi pharmaceutical industry is a key sector within Vision 2030, aiming to enhance health security, diversify the economy, and reduce reliance on imports.
• Growth and Development: The sector has witnessed significant development, enabling the Kingdom to achieve a prominent regional position and pursue global excellence.
• Factors Contributing to Success: This growth is attributed to a clear strategic vision, effective localization programs, and strategic partnerships.
• Government Support: The local industry benefits from direct government support, including exemptions and incentives, allowing for subsidized or lower prices for locally manufactured medicines compared to imports.
• Generating Value-Added Jobs: Localization efforts, or “Saudization,” create valuable specialized jobs in manufacturing, R&D, quality control, and pharmaceutical operations management.
• Developing Saudi Talent: The establishment of advanced training and qualification programs in collaboration with global companies and Saudi universities and technical colleges contributes to raising national competencies.
• Strategic Pillars of Localization: Vision 2030 supports the localization of medical industries through initiatives like “Made in Saudi,” the Pharmaceutical Industry Localization Program, support for local products, the Industrial Fund, and incentives from the Ministry of Investment and the Saudi Food and Drug Authority (SFDA).
• International Partnerships: Strategic partnerships with global companies are crucial for technology transfer and local production of advanced medicines, including oncology and biological products.
• Specialized Industrial Cities: The development of specialized industrial cities like Sudair aims to attract international companies and increase the value of pharmaceutical and medical products.
• Growing Market: The Saudi pharmaceutical market is the largest in the Arab region, driven by increasing local demand, expanding healthcare services, a growing population, and rising health awareness. Its strategic geographic location also makes it attractive for investment.
• Self-Sufficiency and Security: The shift from being primarily an importer to a producer and exporter of medicines is a strategic transformation aimed at building an integrated national pharmaceutical system and enhancing drug security.
• Evolution of the Industry: Prior to the 1970s, Saudi Arabia was almost entirely reliant on imported medicines. The need for a local industry became apparent with population growth and healthcare advancements. Early efforts focused on achieving a degree of self-sufficiency, particularly in essential medicines and antibiotics.
• SFDA’s Role: The establishment of the Saudi Food and Drug Authority (SFDA) in 2003 has played a significant role in regulating the industry and facilitating its development.
• Quantitative Achievements: As of the source date, there were approximately 84 licensed drug factories and 148 licensed medical device and equipment factories in the Kingdom, with substantial investments. Saudi pharmaceutical exports also saw significant growth.

II. Drug Security and Challenges

• Definition of Drug Security: The state’s ability to provide essential medicines in a sustainable, safe, and timely manner at suitable prices and high quality for all segments of society. It goes beyond mere quantity to include rapid response to crises, manufacturing localization, diversification of supply sources, and managing the entire value chain.
• COVID-19 Impact: The pandemic highlighted the critical importance of national drug security and the need for a resilient national pharmaceutical system. Saudi Arabia’s proactive plans allowed it to respond effectively.
• Vision 2030 Goals for Drug Security: Key goals include increasing local manufacturing to 70%, boosting the pharmaceutical sector’s contribution to the national product, and establishing modern infrastructure for manufacturing and research.
• Incentives and Policies: The government has implemented programs, financial and legislative incentives, and encouraged partnerships to stimulate investment in the local pharmaceutical sector.
• Challenges: Despite progress, challenges remain, including a shortage of specialized technical and biological expertise, high operating costs compared to some international markets, and some regulatory hurdles (though improving).
• Global Competition: The local industry faces competition from global companies in terms of cost and quality.
• Reliance on Imported Raw Materials: Limited local availability of raw materials necessitates continued reliance on imports for certain components.

III. Innovation and Technology

• Focus on Innovation and R&D: Saudi Arabia is emphasizing innovation and R&D in the pharmaceutical sector, supporting clinical research and local development.
• Adopting Modern Technologies: The Kingdom is focusing on adopting modern technologies like artificial intelligence (AI) in drug manufacturing to improve production, accelerate innovation, and develop personalized treatments.
• Digital Transformation: Building digital platforms to connect stakeholders in the sector and establishing drug innovation centers within universities are part of the digital transformation efforts.
• AI Applications: Future applications of AI include predictive systems, big data analysis, and virtual reality for training.
• Cybersecurity: Increased reliance on digitalization necessitates strengthening cybersecurity for critical data in the sector.
• Universities’ Role: Saudi universities play a central role in promoting digital transformation through developing research infrastructure and qualifying specialized national personnel, in line with Vision 2030’s focus on localizing vital industries.
• Investment in Biotechnology: Major universities are establishing research centers in biotechnology and AI to support the development of innovative medicines.

IV. Environmental Sustainability

• Integration with Vision 2030: The development of the Saudi pharmaceutical industry aligns with Vision 2030’s commitment to achieving a balance between industrial growth and environmental protection.
• “Green Industries” Technologies: Local pharmaceutical factories are adopting environmentally friendly technologies to reduce carbon emissions, rationalize resource use, and promote sustainable manufacturing.
• Waste Management: Advanced systems for managing medical and pharmaceutical waste are being developed to ensure safe disposal of chemical and pharmaceutical materials.
• Government and SFDA Efforts: The government and the SFDA are working to ensure factories’ compliance with strict environmental standards and promote the use of renewable energy in production lines.
• AI and IoT for Environmental Monitoring: Integrating AI and the Internet of Things (IoT) in monitoring the environmental impact of factories is a crucial step towards enhancing environmental efficiency and transparency in environmental performance reporting.
• Attracting International Companies: Commitment to environmental sustainability helps attract global companies that require high environmental responsibility standards in their investments.

V. Role of Women in the Industry

• Leadership and Contribution: Women like Professor Samira Ibrahim Islam have played a pioneering role in the history of medicine and pharmacy in the Kingdom, contributing significantly to research and the development of pharmaceutical policies.
• Creating Opportunities: The expected expansion in biotechnology, a field requiring precise specializations, will provide significant opportunities for Saudi women to participate in advanced genetic research and drug development.
• Part of Strategic Transformation: Empowering women is an essential part of Saudi Arabia’s strategic transformation towards becoming a global hub in healthcare industries.
• Demonstrated Capability: Saudi women have demonstrated exceptional capabilities in various fields within the healthcare sector, from research and development to manufacturing and management.
• Future Prospects: With continued government support and empowerment, the Kingdom is expected to witness a qualitative leap in women’s participation in the pharmaceutical industry, enhancing self-sufficiency and global competitiveness.
• Alignment with Vision 2030: The future is promising for Saudi women in this vital sector, aligning with Vision 2030’s aspirations for an economy based on innovation and the achievement of national independence in healthcare and national competencies.

VI. Other Relevant Information

• The source also briefly touches upon:
• ARAMCO’s environmental efforts in the Al-Shaibah oil field, including wildlife preservation and reintroduction.
• The concept of media regulation and professional registration for practitioners.
• A brief philosophical discussion on Theseus’s paradox and identity.
• Mentions of cultural and artistic events, including Art Dubai and Down Town Design Riyadh.
• Discussion of the Saudi Rial’s history and its symbol.
• The global competition in AI development between the US and China.
• The history and achievements of Al-Ahli football club.

Quiz

1. What is one of the primary goals for the Saudi pharmaceutical industry within Vision 2030?
2. How does the Saudi government support the local pharmaceutical industry?
3. What types of specialized jobs are being created as a result of the localization efforts (Saudization) in the pharmaceutical sector?
4. Why are international partnerships important for the growth of the Saudi pharmaceutical industry?
5. What was the state of the Saudi pharmaceutical industry before the 1970s?
6. Define the concept of “drug security” as described in the source.
7. How did the COVID-19 pandemic impact the understanding of drug security?
8. What role do Saudi universities play in the digital transformation of the pharmaceutical industry?
9. How is the Saudi pharmaceutical industry addressing environmental sustainability?
10. What significant role have women like Professor Samira Ibrahim Islam played in the Saudi pharmaceutical and medical fields?

Answer Key

1. One of the primary goals is to enhance health security, diversify the economy, and reduce reliance on imports.
2. The Saudi government supports the local pharmaceutical industry through direct support, including exemptions and incentives, which allows for lower prices for locally produced medicines.
3. Specialized jobs being created include roles in manufacturing, R&D, quality control, and pharmaceutical operations management.
4. International partnerships are important for technology transfer and the local production of advanced medicines.
5. Before the 1970s, the Saudi pharmaceutical industry was almost entirely reliant on importing medicines from abroad.
6. Drug security is defined as the state’s ability to provide essential medicines in a sustainable, safe, and timely manner at suitable prices and high quality for all segments of society.
7. The COVID-19 pandemic highlighted the critical importance of national drug security and the need for a resilient national pharmaceutical system.
8. Saudi universities play a central role by developing research infrastructure and qualifying specialized national personnel for the industry’s digital transformation.
9. The Saudi pharmaceutical industry is addressing environmental sustainability by adopting environmentally friendly technologies, developing waste management systems, and promoting renewable energy use.
10. Women like Professor Samira Ibrahim Islam have played a pioneering role in the history of medicine and pharmacy, contributing significantly to research and the development of pharmaceutical policies.

Essay Questions

1. Analyze the multi-faceted approach Saudi Arabia is taking within Vision 2030 to achieve drug security and enhance the competitiveness of its pharmaceutical industry on a regional and global scale.
2. Discuss the historical evolution of the Saudi pharmaceutical industry, from its reliance on imports to its current strategic positioning, highlighting the key milestones and governmental initiatives that have driven this transformation.
3. Evaluate the opportunities and challenges faced by the Saudi pharmaceutical industry, considering factors such as government support, global competition, the need for specialized expertise, and the integration of advanced technologies like AI.
4. Examine the role of innovation and technology, particularly artificial intelligence and digitalization, in shaping the future of the Saudi pharmaceutical industry and its contribution to achieving self-sufficiency and developing advanced medical treatments.
5. Discuss the significance of empowering women and developing national competencies within the pharmaceutical sector, explaining how these efforts contribute to both economic growth and the achievement of the broader goals outlined in Vision 2030.

Glossary of Key Terms

• Vision 2030: Saudi Arabia’s strategic framework for reducing its dependence on oil, diversifying its economy, and developing public service sectors such as health, education, infrastructure, recreation, and tourism.
• Drug Security: The state’s ability to provide essential medicines in a sustainable, safe, and timely manner at suitable prices and high quality for all segments of society.
• Localization (Tawteen or Saudization): The policy of increasing the proportion of Saudi nationals employed in the workforce and the production of goods and services within Saudi Arabia.
• SFDA (Saudi Food and Drug Authority): The governmental body responsible for regulating food, drugs, and medical devices in Saudi Arabia.
• R&D (Research and Development): The process of investigating and developing new products, processes, or services.
• Biotechnology: The exploitation of biological processes such as genetic manipulation of microorganisms for the production of antibiotics, hormones, etc.
• Artificial Intelligence (AI): The theory and development of computer systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, decision-making, and translation between languages.
• Digital Transformation: The integration of digital technology into all areas of a business, fundamentally changing how it operates and delivers value to customers.
• Environmental Sustainability: The ability to maintain ecological processes, functions, biodiversity, and productivity into the future.
• Al-Shaibah: A significant oil field in Saudi Arabia, mentioned in the source for ARAMCO’s environmental initiatives in the surrounding area.
• Sudair: A specialized industrial city in Saudi Arabia, highlighted for its role in attracting investment in the pharmaceutical and chemical sectors.
• Theseus’s Paradox: A philosophical puzzle about identity and change, questioning whether an object that has had all of its components replaced remains the same object.
• Art Dubai: An international art fair held annually in Dubai.
• Down Town Design Riyadh: A design exhibition or event mentioned in the context of the growing design sector in Saudi Arabia.
• Saudi Rial: The currency of Saudi Arabia.
• G20 (Group of Twenty): An international forum for the governments and central bank governors from 19 countries and the European Union.

Briefing Document: Key Developments and Trends in Saudi Arabia (May 2025)

This briefing document synthesizes information from various sources to highlight significant developments and key themes in Saudi Arabia, focusing on the pharmaceutical industry, technological advancement, environmental conservation, social progress, and cultural initiatives, all within the context of Vision 2030.

Theme 1: Saudi Arabia’s Ambition in the Pharmaceutical Industry

A central and recurring theme is Saudi Arabia’s strategic focus on developing a robust domestic pharmaceutical industry, aiming for self-sufficiency and global leadership. This is a cornerstone of Vision 2030, driven by the need to enhance health security, diversify the economy, and reduce reliance on imports, particularly in light of global health crises.

• Strategic Importance: The pharmaceutical industry is considered a vital pillar of national health and economic security. The COVID-19 pandemic specifically underscored the critical need for a resilient national pharmaceutical system.
• Vision 2030 Alignment: Vision 2030 explicitly targets increasing the local manufacturing share of medicines to 70%, enhancing the pharmaceutical sector’s contribution to the national product, and establishing a modern infrastructure including factories, research centers, and innovation incubators.
• Government Support and Initiatives: The government is providing significant direct support, including financial incentives, exemptions, and streamlined regulatory processes through entities like the Ministry of Investment, the Saudi Industrial Development Fund, and the Saudi Food and Drug Authority (SFDA). Initiatives like “Made in Saudi” and the National Industrial Development and Logistics Program (NIDLP) are highlighted as crucial.
• Market Growth and Investment Opportunities: The Saudi pharmaceutical market is the largest in the Arab region, exceeding 30 billion riyals annually. Its strategic location, developed infrastructure, and increasing demand due to population growth, rising life expectancy, and health awareness make it highly attractive for investment.
• Challenges: Despite rapid progress, challenges remain, including a shortage of specialized technical expertise (particularly in biologicals and advanced fields), higher operating costs compared to some international markets, previously slow regulatory procedures (though improved recently), and limited local raw material availability.

Key Facts/Ideas:

• The goal is to transform Saudi Arabia from a primary consumer to a producer and exporter of pharmaceuticals.
• Significant progress has been made in localizing production of essential medicines, including those for chronic diseases, immunology, and cancer, as well as medical devices like ventilators and blood glucose strips.
• The number of licensed pharmaceutical factories has reached approximately 84, with investments totaling around 7.5 billion riyals, meeting 28% of the Saudi market’s value and 42% of its unit needs.
• Pharmaceutical exports are growing rapidly, exceeding 1.5 billion riyals, with a 33.3% increase in the past year, reaching 2 billion riyals.
• Partnerships with global pharmaceutical companies are actively pursued to facilitate technology transfer and produce advanced medicines locally.
• The SFDA, established in 2003, has played a crucial role in developing the sector’s regulatory framework.
• The increase in medicine sales in the first quarter of 2025 (2.2 billion dollars) compared to the same period in 2024 (1.9 billion dollars) demonstrates market growth.

Theme 2: Technological Advancement and Global Competition

The sources touch upon Saudi Arabia’s engagement with advanced technologies, specifically highlighting the global competition in Artificial Intelligence (AI) and the importance of digital transformation within the pharmaceutical industry.

• AI Competition: The rapid advancements in AI, particularly from Chinese companies like “Deep Seek,” are posing a significant challenge to Western dominance in the technological sphere. US companies are responding with new tools like “Deep Research.”
• Strategic Importance of Chip Manufacturing: The competition in AI is closely linked to the manufacturing of electronic chips, where the US currently holds an advantage, but China is making rapid progress. US export restrictions on advanced chips have pushed Chinese companies to innovate alternative solutions.
• Huawei’s Efforts: Huawei is mentioned for its focus on developing its own AI processors like the “Ascend” series, aimed at improving data processing efficiency in deep learning and big data analytics.
• Digital Transformation in Pharmaceuticals: Saudi Arabia is emphasizing the integration of AI and the Internet of Things (IoT) in the pharmaceutical industry to improve efficiency, monitoring, and potentially develop personalized treatments. This includes building digital platforms to connect stakeholders and establishing innovation centers.
• Cybersecurity: The increasing reliance on digitalization necessitates strong cybersecurity measures, and Saudi Arabia is strengthening its efforts in this area, including training advanced cyber security personnel.

Key Facts/Ideas:

• The competition between the US and China in AI has strategic geopolitical and economic implications.
• Chinese companies are making significant investments in AI infrastructure and chip development.
• Huawei’s Ascend processors are an example of Chinese efforts to reduce reliance on foreign technology.
• Saudi universities are playing a key role in digital transformation within the pharmaceutical sector through research and talent development, aligning with Vision 2030’s focus on vital industries.

Theme 3: Environmental Sustainability

Environmental considerations are integrated into Saudi Arabia’s development plans, particularly within the industrial sector.

• Alignment with Vision 2030: The rapid growth of the pharmaceutical industry is occurring within the framework of Vision 2030’s emphasis on achieving a balance between industrial growth and environmental protection.
• Green Industries and Sustainable Practices: Saudi pharmaceutical factories are adopting “Green Industries” technologies to reduce carbon emissions, conserve natural resources, and promote sustainable manufacturing.
• Waste Management: Advanced systems are being developed for managing medical and pharmaceutical waste to ensure safe disposal of chemicals and protect the environment.
• Renewable Energy: The use of renewable energy, such as solar power, in industrial cities like “Sedir” and “Knowledge City” is being encouraged through incentives.
• Environmental Monitoring: The integration of AI and IoT is being used for real-time monitoring of emissions, air quality, and water quality in pharmaceutical factories to improve environmental decision-making and transparency.
• Attracting Global Companies: Adherence to high environmental standards is seen as a way to attract global companies seeking partners with strong environmental responsibility.

Key Facts/Ideas:

• Environmental sustainability is a key aspect of Saudi Arabia’s industrial development strategy.
• Specific initiatives are in place to promote environmentally friendly practices and waste management in the pharmaceutical industry.

Theme 4: Social Progress and Empowerment

The sources highlight advancements in social spheres, including the empowerment of women and improvements in the work environment.

• Women’s Empowerment: The empowerment of women is presented as a fundamental part of the strategic transformation under Vision 2030, particularly their increasing participation in the healthcare sector, from research and development to manufacturing and management. Professor Samira Ibrahim Islam is highlighted as a pioneering figure in medicine and pharmacy, paving the way for future generations of Saudi women.
• Work Environment: Significant improvements are being made to the work environment, driven by Vision 2030’s focus on sustainable development and improving the quality of life. This includes developing labor legislation, providing supportive work environments for women and youth, and encouraging companies to adopt best practices in occupational health and safety.
• Impact on Productivity: Improvements in the work environment are seen as contributing to increased employee satisfaction, diversity, inclusivity, and ultimately, higher productivity.

Key Facts/Ideas:

• Vision 2030 is a driving force behind the empowerment of Saudi women in various sectors.
• Improvements in the work environment are contributing to a more attractive and productive workforce.

Theme 5: Cultural and Historical Preservation and Promotion

Several sections touch upon the rich history and culture of Saudi Arabia, its promotion, and its role in shaping the national identity.

• Historical Significance of Najd and the Arabian Peninsula: The historical journeys of scholars from Najd to centers of learning are mentioned, highlighting the deep roots of knowledge and intellectual exchange in the region.
• Cultural Heritage: The Arabian Peninsula is presented as a cradle of human civilizations and a meeting point of knowledge, with a long history offering continuous discovery.
• “Dureesha”: A Symbol of Saudi Culture: The concept of “Dureesha” (window) is used as a metaphor for exploring Saudi life and culture, representing a gateway to memory and dreams.
• Art and Design: The sources mention participation in international art exhibitions like “Art Dubai” and the organization of local design events like “Downtown Design Riyadh,” showcasing Saudi and regional artistic talent and promoting the design sector.
• The Saudi Riyal: The symbol of the Saudi Riyal is highlighted as representing the national currency and Saudi Arabia’s growing position on regional and international stages, particularly within the G20. The history of the Riyal is traced back to the unification of the Kingdom.

Key Facts/Ideas:

• Saudi Arabia values its historical and cultural heritage.
• Cultural initiatives and participation in international events are promoting Saudi art and design.
• The Saudi Riyal is a symbol of national identity and economic standing.

Theme 6: Sports and Achievements

The performance of Saudi football clubs is discussed, showcasing national pride and achievements in the sports arena.

• Al-Ahli Club’s Asian Ambition: Al-Ahli football club’s journey in the AFC Champions League is highlighted, emphasizing their role in representing Saudi football and the anticipation surrounding their potential to win the title.
• Fan Support: The immense support for Al-Ahli, demonstrated by the unprecedented demand for tickets for the final match, underscores the passion for football in the Kingdom.
• Historical Achievements of Al-Ittihad Club: The article highlights the historical dominance and achievements of Al-Ittihad club, emphasizing their long history, numerous titles (including league and cup wins), and consistent participation in the Saudi league since its inception. This section aims to solidify Al-Ittihad’s position as a leading and pioneering club in Saudi football history.
• Football Governance and Documentation: The article mentions the approval of a comprehensive report on Saudi football history and documentation, aimed at bringing order and transparency to the recording of championships and club achievements. This initiative seeks to end historical disputes and recognize the contributions of pioneering clubs.

Key Facts/Ideas:

• Saudi football is a significant aspect of national culture and pride.
• The level of fan support for clubs is extremely high.
• There is an ongoing effort to accurately document and recognize the historical achievements of Saudi football clubs.

Theme 7: Reflections on Identity and Existence

One philosophical excerpt delves into the concept of identity and change using the Ship of Theseus paradox.

• The Ship of Theseus Paradox: This ancient philosophical puzzle is presented as a means to explore the changing nature of identity over time. The question of whether an object remains the same after all its components have been replaced is posed.
• Existential Questions: The paradox leads to broader questions about existence, meaning, and the human condition, suggesting that these remain subjects of ongoing philosophical and narrative exploration.

Key Facts/Ideas:

• Philosophical concepts are being explored in the provided sources.
• The Ship of Theseus paradox is used to stimulate reflection on identity and change.

In conclusion, these sources provide a multifaceted snapshot of Saudi Arabia’s current trajectory, showcasing its ambitious pursuit of economic diversification and self-sufficiency through strategic initiatives like Vision 2030, with a particular emphasis on the burgeoning pharmaceutical industry. Alongside this economic push, there is a clear focus on technological advancement, environmental responsibility, social progress through empowerment, the preservation and promotion of cultural heritage, and a deep passion for sports. Underlying these developments are reflections on national identity and existence, contributing to a dynamic and evolving national landscape.

What is Saudi Vision 2030 and how does it relate to the pharmaceutical industry?

Saudi Vision 2030 is a strategic framework aimed at diversifying Saudi Arabia’s economy and reducing its dependence on oil. A key pillar of this vision is the development of the healthcare sector, with a strong emphasis on localizing the pharmaceutical industry. This means increasing domestic drug manufacturing, encouraging innovation and research, and reducing reliance on imported medicines. Vision 2030 initiatives, such as “Made in Saudi” and the Pharmaceutical Industries Localization Program, along with support from government bodies like the Ministry of Investment, the Saudi Industrial Development Fund, and the Saudi Food and Drug Authority (SFDA), are driving this transformation.

How is Saudi Arabia encouraging foreign investment and technology transfer in its pharmaceutical sector?

Saudi Arabia is actively seeking strategic partnerships with global pharmaceutical companies. These partnerships are crucial for transferring technology and expertise to the Kingdom. By offering financial and legislative incentives, such as those provided by the Ministry of Investment and the SFDA, Saudi Arabia is creating an attractive environment for international companies to establish local manufacturing facilities or engage in joint ventures. This is helping to develop the local industry, particularly in the area of advanced and biological drugs, and contributes to the creation of skilled jobs for Saudi nationals.

What are the key achievements and progress in the Saudi pharmaceutical industry’s localization efforts?

Significant progress has been made in localizing drug manufacturing in Saudi Arabia. The number of licensed pharmaceutical factories has reached around 84, with total investments nearing 7.5 billion Saudi Riyals. These factories meet a substantial portion of the local market’s needs. Saudi pharmaceutical exports are also growing, indicating a strengthening industrial base. Efforts are focused on localizing essential medications, including those for chronic diseases, immune system disorders, and cancer, as well as medical devices and equipment. The rapid response to the COVID-19 pandemic, including increasing the production capacity of masks and disinfectants, demonstrated the effectiveness of these localization initiatives and government support.

How is Saudi Arabia fostering innovation and research within the pharmaceutical sector?

Innovation and scientific research are being actively stimulated to support the growth of the pharmaceutical industry. Vision 2030 initiatives encourage investment in biotechnology and local research and development (R&D). Universities are playing a crucial role by developing research infrastructure and training specialized national cadres in areas like pharmaceutical science and biotechnology. The integration of advanced technologies such as Artificial Intelligence (AI) and the Internet of Things (IoT) is being promoted for drug development, production optimization, and enhancing environmental efficiency in factories.

What challenges does the Saudi pharmaceutical industry face despite its rapid growth?

Despite significant advancements, the Saudi pharmaceutical industry still faces certain challenges. These include a shortage of specialized technical and biological expertise, particularly in advanced fields. The cost of operations compared to some international markets can also be a hurdle. While regulatory processes have improved, some procedures, like registration and pricing, have historically faced delays. Additionally, a limited local supply of raw materials necessitates continued reliance on imports for certain components, and the industry faces competition from established global companies in terms of cost and quality.

What is the role of Saudi women in the development of the pharmaceutical and healthcare sectors?

Saudi Vision 2030 strongly supports the empowerment of women and their active participation in various sectors, including healthcare and pharmaceuticals. Women are increasingly contributing to scientific research, drug development, and manufacturing. Prominent figures like Professor Samira Ibrahim Islam have paved the way for future generations of Saudi women in the field of pharmacology. The growth in the biotechnology sector is expected to create significant opportunities for Saudi women in advanced genetic research and drug development, further enhancing the Kingdom’s self-sufficiency and competitiveness.

How is Saudi Arabia addressing environmental sustainability in its growing pharmaceutical industry?

Saudi Arabia is committed to achieving environmental sustainability within its pharmaceutical industry, aligning with global trends and Vision 2030 goals. The focus is on implementing “green industries” techniques to reduce carbon emissions and conserve natural resources. Initiatives include developing advanced waste management systems for safe disposal of chemical and pharmaceutical waste, adopting stringent environmental compliance standards for factories, and promoting the use of renewable energy sources like solar power in industrial cities. Digital technologies such as AI and IoT are also being used to monitor environmental impact and enhance transparency in reporting.

Beyond pharmaceuticals, what other key developments and themes are highlighted in the provided sources?

The sources touch upon several other significant developments and themes in Saudi Arabia. These include:

• Environmental Conservation: Efforts by entities like Saudi Aramco to protect and rehabilitate natural environments around oil fields, transforming them into protected areas with diverse flora and fauna.
• Cultural and Artistic Scene: The burgeoning art and design landscape, with exhibitions like “Art Dubai 2025” and “Downtown Design Riyadh” showcasing Saudi and regional artistic talent and promoting cultural exchange.
• Work Environment Transformation: Significant improvements in workplace environments driven by Vision 2030, focusing on employee well-being, work-life balance, and fostering a more inclusive and diverse workforce.
• Technological Competition: The ongoing global competition in artificial intelligence and semiconductor manufacturing, with a focus on the rivalry between the United States and China and the strategic importance of advanced chips.
• Historical and Cultural Identity: Exploration of historical journeys of Saudi scholars, the concept of identity and change through the Ship of Theseus paradox, and the role of arts and culture in reflecting Saudi life and heritage.
• Sports Development: Significant investments and achievements in the sports sector, as evidenced by the high demand for tickets for major football matches and the historical achievements of prominent Saudi clubs.
• Media Regulation: The establishment of regulations for media and influencers to professionalize the field and address the challenges of the evolving media landscape.
• Healthcare and Well-being: Discussions around mental health and the importance of healthy parenting practices, exemplified by the concept of Danish parenting styles.

By Amjad Izhar
Contact: amjad.izhar@gmail.com
https://amjadizhar.blog

Affiliate Disclosure: This blog may contain affiliate links, which means I may earn a small commission if you click on the link and make a purchase. This comes at no additional cost to you. I only recommend products or services that I believe will add value to my readers. Your support helps keep this blog running and allows me to continue providing you with quality content. Thank you for your support!